Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

152.10 -2.42 (-1.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
82 83 Next >
5 Companies Buying Back Their Stock Aggressively in This Bear Market
These companies clearly think their shares are good values. 
Via The Motley Fool
2 Nasdaq 100 Stocks That Could Plunge as Much as 88%, According to Wall Street
Select analysts believe these widely held growth stocks could plummet from their current price. 
Via The Motley Fool
Check Out What Whales Are Doing With MRNA
Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
5 Cheap Stocks Beginning Investors Can Buy Right Now
Investing in these five stocks could be a great way to start putting your money to work in the stock market. 
Via The Motley Fool
Why Moderna Stock Could Still Be More Than 50% Overvalued
One valuation model could hint at a further decline for the vaccine stock. 
Via The Motley Fool
The 7 Best Pharma Stocks to Buy Now
Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks. 
Via InvestorPlace
8 Analysts Have This to Say About Moderna
Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter: 
Via Benzinga
Why Moderna Stock Jumped on Monday
The market was pleased with the biotech's latest regulatory win. 
Via The Motley Fool
The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings
Investors are looking for one key positive metric from Novavax's third-quarter earnings. 
Via Investor's Business Daily
Is Moderna a Bad-News Buy?
Moderna is heading for a big transition. 
Via The Motley Fool
3 Things You Need to Know About Moderna's Post-Pandemic Revenue
Is the next phase of revenue growth just ahead? 
Via The Motley Fool
Did Vaccine Stocks Just Get Their Last Boost?
Some positive news sent their share prices higher, but biotech companies will need to find other ways to make money. 
Via The Motley Fool
7 Cash-Rich Stocks to Buy for Peace of Mind
It pays to hold cash-rich stocks that can weather any storm because of their financial strength. Investors may want to watch these seven. 
Via InvestorPlace
This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid Boosters
Pfizer and BioNTech tested their updated Covid booster against the original shot. 
Via Investor's Business Daily
Moderna Inc. (MRNA) Q3 2022 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Moderna Plummets After Slashing 2022 Outlook Following Massive Quarterly Miss
The drugmaker notes supply issues have delayed some of its deliveries. 
Via Investor's Business Daily
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
A mixed jobs report and heavy earnings swung stocks. 
Via Investor's Business Daily
BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market
German Chancellor Olaf Scholz agreed to allow expatriates in China to use BioNTech SE (NASDAQ: BNTX) made COVID-19 vaccine. BioNTech would be the first non-Chinese coronavirus vaccine in China, as... 
Via Benzinga
Moderna To 170? Plus This Analyst Slashes PT On Funko By 50%
  Morgan Stanley slashed the price target on Moderna, Inc. (NASDAQ: MRNA) from $175 to $170. Moderna shares fell 0.7% to trade at $146.49 on Friday. 
Via Benzinga
Moderna's Earnings Collapsed. Time to Sell?
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills. 
Via The Motley Fool
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... 
Via Benzinga
Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. 
Via Benzinga
BioNTech Shares Up On Hope For Combined Flu, Covid Shot
The shot will combine Pfizer's quadrivalent flu shot with the bivalent Covid booster. 
Via Investor's Business Daily
Peloton (PTON) Stock Slumps on Gloomy Holiday Forecast
Peloton (PTON) stock is falling on Thursday after the exercise equipment company provided an outlook update for the holidays. 
Via InvestorPlace
Why Is Moderna (MRNA) Stock Down 5% Today?
Moderna (MRNA) stock is falling on Thursday following the release of the vaccine company's earnings report for the third quarter of 2022. 
Via InvestorPlace
What's Going On With Moderna Stock Thursday?
Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday after the company reported worse-than-expected financial results. 
Via Benzinga
Moderna Shares Deep Dive After Lower COVID-19 Vaccine Sales Weigh On Q3 Sales, Profits
 
Via Benzinga
Moderna: Q3 Earnings Insights
Moderna (NASDAQ:MRNA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Moderna missed estimated earnings... 
Via Benzinga
Moderna, Starbucks And 3 Stocks To Watch Heading Into Thursday
With US stock futures trading slightly lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
82 83 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.